Power3 Medical Products, Inc. (PWRM.OB)
NuroPro is a series of three separate and distinct blood serum tests designed to diagnose: Alzheimer’s, Parkinson’s or Lou Gehrig’s disease (ALS) in individuals.
Alzheimer’s disease is among the most well known form of dementia, a broad term when it comes to forgetfulness and other intellectual abilities critical enough to obstruct everyday life.
Parkinson’s disease (PD) is associated with a team of disorders called motor system disorders, which are the result of the losing of dopamine-producing brain cells. Some fundamental symptoms of PD are generally tremor, or moving in hands, arms, legs, jaw, and face; hardness, or maybe tightness of the limbs and trunk; bradykinesia, or slowness of movement; and postural lack of stability, or reduced balance as well as co-ordination.
Amyotrophic lateral sclerosis (abbreviated ALS, also referred to as Lou Gehrig’s disease) is a form of motor neuron disease. ALS is a progressive, fatal, neurodegenerative disease caused by the degeneration of motor neurons, the nerve cells in the central nervous system that control voluntary muscle movement. The condition is often called Lou Gehrig’s disease in North America, after the famous New York Yankees baseball player who was diagnosed with the disease in 1939.
The test is based on proteomic technology, in which a blood serum sample drawn from a patient, monitors the concentration of selected biomarkers residing in a panel of blood serum protein biomarkers that determines if a patient has a Neurodegenerative disease, such as Alzheimer’s, Parkinson’s or Lou Gehrig’s Disease (ALS). The biomarkers in the panel have been selected for their ability to discriminate diseased from non-diseased patients. ( Read More http://crweselect.com/22269/stock-alerts/pwrm-nhpr-cwtr-mntg-zhne-crwese... )